Ardent Health (ARDT) Stock Forecast: StockMap's 2-Week Call
ARDT stock forecast: StockMap's model leans Outperform on Ardent Health for the two weeks after the Nov 19 close, toward ARDT doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 4 two-week windows on ARDT since Aug 21; by chance, a call on the same dates was right 69% of the time.
Ardent Health last closed at $14.50, +0.69% on the session.
Against the IVW growth benchmark the position is +3.02% over the forecast window.
Ardent Health's market cap is $2.04B as of November 19, 2026.
Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 24 (too close to call).
Where ARDT sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 5 bullish and 10 bearish.
Agreement across those insights is 33%.
22 daily calls for ARDT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Ardent Health in the 63rd percentile on valuation, where 100 is best.
Ardent Health is classified under Health Care / Health Care Providers & Services.
StockMap tracks Ardent Health as the 43rd largest of the 87 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 52 Neutral, 18 Moderate Underperform, 12 Moderate Outperform and 5 Strong Underperform.
On that composite Ardent Health ranks 8th of 87 in the group, against a group median of -0.06.